Andreas Abend
Merck & Co Inc
Director
Andreas Abend, PhD is a Director in the Analytical Sciences group in the Pharmaceutical Sciences department of Merck’s Research Labs. His group provides analytical support to early formulation development, the release and stability testing of clinical supplies, and is overall responsible to ensure new drug products entering late stage clinical development are well characterized. In addition to his responsibilities related to analytical support of product development, he is a member of Merck’s Biopharmaceutical Advisory Team, which is a resource to product development teams seeking cross-functional in-put towards biopharmaceutical and regulatory challenges. During his 20-year career at Merck, Andreas supported drug product and API development and provided technical support to in-line products.
Andreas is the co-leader of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Dissolution Working group, and a member of the Biopharmaceutical Technical Committee of the Product Quality Research Institute.
In the late 1990, Andreas was a postdoctoral fellow at the Institute for Enzyme Research in Dr. Perry Frey’s lab at the University of Wisconsin, Madison WI. He got his PhD in Organic Chemistry from the Universität Karlsruhe TH in Germany under the supervision of Dr. Janos Rétey.
Andreas is the co-leader of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Dissolution Working group, and a member of the Biopharmaceutical Technical Committee of the Product Quality Research Institute.
In the late 1990, Andreas was a postdoctoral fellow at the Institute for Enzyme Research in Dr. Perry Frey’s lab at the University of Wisconsin, Madison WI. He got his PhD in Organic Chemistry from the Universität Karlsruhe TH in Germany under the supervision of Dr. Janos Rétey.